 Racivir is a racemic mixture of the two β-enantiomers of emtricitabine (FTC), (-)-FTC and (+)-FTC.Racivir has excellent oral bioavailability and has the advantage of needing to be taken only once a day.Racivir can be considered to be used in combination of two NRTIs and has shown promising antiviral activity when used in combination.